(Q44817216)

6 December 2017

Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies (English)

1 reference

6 December 2017

1 reference

Hamaki T

1

1 reference

6 December 2017

Kami M

2

1 reference

6 December 2017

Kim SW

3

1 reference

6 December 2017

Onishi Y

4

1 reference

6 December 2017

Kishi Y

5

1 reference

6 December 2017

Murashige N

6

1 reference

6 December 2017

Hori A

7

1 reference

6 December 2017

Kojima R

8

1 reference

6 December 2017

Sakiyama M

9

1 reference

6 December 2017

Imataki O

10

1 reference

6 December 2017

Heike Y

11

1 reference

6 December 2017

Tanosaki R

12

1 reference

6 December 2017

Masuo S

13

1 reference

6 December 2017

Miyakoshi S

14

1 reference

6 December 2017

Taniguchi S

15

1 reference

6 December 2017

Tobinai K

16

1 reference

6 December 2017

Takaue Y

17

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Bone Marrow Transplantation

6 December 2017

1 reference

6 December 2017

33

1 reference

6 December 2017

9

1 reference

6 December 2017

891-900

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704477

6 December 2017

0 references

cites work

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Management of fever in patients with cancer and treatment-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Neurotoxicity of purine analogs: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

WT1 as a novel target antigen for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704477

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704477

1 reference

6 December 2017

1 reference